Cas:1093951-66-6 2-methoxy-4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine manufacturer & supplier

Chemical Name:2-methoxy-4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

CAS.NO:1093951-66-6

Synonyms:rw3589

Molecular Formula:C₁₃H₂₀BNO₃

Molecular Weight:249.11400

HS Code:2934999090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:40.58000

Exact Mass:249.15400

LogP:1.69780

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like rw3589 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,rw3589 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,rw3589 Use and application,rw3589 technical grade,usp/ep/jp grade.

Related News: RELATED: With cost cuts and asset sales largely wrapped, Takeda gears up for growth: CEO Dregeoside Aa1 manufacturers After the IPO, he now owns a 53% stake, worth $3.1 billion, plus roughly $100 million in cash and other investments, including a winery in northeastern Italy. His sons Franco and Marco (the company’s vice chairman) each own 12% stakes worth about $730 million apiece. 5,5-dimethyl-1,3-dioxane suppliers Soliris, first approved for generalized myasthenia gravis (gMG) in 2017, carries a list price of about $470,000 annually. But to ICER, that cost is “well beyond typical thresholds.” 2-[1-amino-2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]benzoic acid vendor & factory RELATED: With cost cuts and asset sales largely wrapped, Takeda gears up for growth: CEO,the strategy lays out the challenges that researchers and institutions are facing, including skills shortages in particular disciplines, limited opportunities for career progression and issues of bullying and harassment.